Page last updated: 2024-11-04

3,3-dimethylallyl pyrophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,3-Dimethylallyl pyrophosphate (DMAPP) is a key intermediate in the biosynthesis of terpenes and other isoprenoid compounds. It is a five-carbon branched isoprenoid phosphate ester that is formed from the condensation of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), catalyzed by the enzyme prenyltransferase. DMAPP serves as a substrate for the synthesis of a wide variety of isoprenoids, including monoterpenes, sesquiterpenes, diterpenes, triterpenes, steroids, carotenoids, and ubiquinones. DMAPP is also involved in the biosynthesis of other important biomolecules such as chlorophyll, heme, and vitamin K. The synthesis of DMAPP is a critical step in the mevalonate pathway, a metabolic pathway that produces isoprenoids. DMAPP is also a key intermediate in the non-mevalonate pathway, which is an alternative pathway for isoprenoid biosynthesis. The biosynthesis of DMAPP has been studied extensively, and several methods have been developed for its chemical synthesis. DMAPP is an important target for drug discovery because it is involved in the biosynthesis of a wide range of biomolecules, including many that are essential for human health. DMAPP has been studied for its potential to inhibit the growth of cancer cells, viruses, and bacteria. Studies on DMAPP have led to the development of new drugs for the treatment of cancer, viral infections, and bacterial infections.'

3,3-dimethylallyl pyrophosphate: isomeric with isopentenyl pyrophosphate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

prenyl diphosphate : A prenol phosphate that is a phosphoantigen comprising the O-pyrophosphate of prenol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID647
CHEMBL ID343480
CHEBI ID16057
SCHEMBL ID153577
MeSH IDM0126891

Synonyms (45)

Synonym
3-methyl-but-2-enyl phosphono hydrogen phosphate
3-methylbut-2-en-1-yl trihydrogen diphosphate
CHEBI:16057 ,
prenol pyrophosphate
3,3-dimethylallyl pyrophosphate
3-methylbut-2-enyl phosphono hydrogen phosphate
3-methylbut-2-enyl pyrophosphate
LMPR01010001
diphosphoric acid, mono(3-methyl-2-butenyl) ester (9ci)
3-methyl-2-butenyl pyrophosphate
2-buten-1-ol, 3-methyl-, pyrophosphate (6ci)
dimethylallyl-ppi
diphosphoric acid, mono(3-methyl-2-butenyl) ester
2-buten-1-ol, 3-methyl-, trihydrogen pyrophosphate (7ci,8ci)
dimethylallyl-diphosphate
dimethylallyl-pyrophosphate
dimethylallyl pyrophosphate
prenyl diphosphate
monoprenyl diphosphate
2-isopentenyl diphosphate
358-72-5
C00235
delta2-isopentenyl diphosphate
dmapp
dimethylallyl diphosphate
1X07
DB01785
CHEMBL343480
EPITOPE ID:140428
SCHEMBL153577
diphosphoric acid, p-(3-methyl-2-buten-1-yl) ester
2-buten-1-ol, 3-methyl-, trihydrogen pyrophosphate
3-methylbut-2-enyl pyrophosphate (dimethylallyl-diphosphate)
DTXSID70189331
gamma,gamma-dimethyallyl pyrophosphate ammonium salt
3-methyl-2-buten-1-ol trihydrogen pyrophosphate
diphosphoric acid mono(3-methyl-2-butenyl) ester
3-methyl-2-buten-1-ol pyrophosphate
Q417398
gamma gamma-dimethylallyl pyrophosphate&
bdbm50516699
HY-130573
STARBLD0005067
CS-0109211
AKOS040758082
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
phosphoantigenAny antigen that is a phosphorylated microbial metabolite which activates an immune response in humans.
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
prenol phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (65)

PathwayProteinsCompounds
Metabolism14961108
Metabolism of lipids500463
Metabolism of steroids111135
Cholesterol biosynthesis2249
Regulation of leaf development1722
Steroid Biosynthesis2142
Smith-Lemli-Opitz Syndrome (SLOS)2142
CHILD Syndrome2142
Desmosterolosis2142
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)2142
Lysosomal Acid Lipase Deficiency (Wolman Disease)2142
Ibandronate Action Pathway2143
Simvastatin Action Pathway2143
Pravastatin Action Pathway2143
Rosuvastatin Action Pathway2143
Alendronate Action Pathway2143
Hypercholesterolemia2142
Lovastatin Action Pathway2143
Zoledronate Action Pathway2143
Cerivastatin Action Pathway2143
Risedronate Action Pathway2143
Pamidronate Action Pathway2143
Fluvastatin Action Pathway2143
Atorvastatin Action Pathway2143
Cholesteryl Ester Storage Disease2142
Hyper-IgD Syndrome2142
Mevalonic Aciduria2142
Wolman Disease2142
Secondary Metabolites: Methylerythritol Phosphate and Polyisoprenoid Biosynthesis1121
Secondary Metabolites: Isoprenoid Biosynthesis (Nonmevalonate Pathway)818
Terpenoid Backbone Biosynthesis1322
Cholesterol biosynthesis and metabolism CE(14:0)2250
Cholesterol biosynthesis and metabolism CE(10:0)2250
Cholesterol Biosynthesis and Metabolism CE(12:0)2250
Cholesterol Biosynthesis and Metabolism CE(16:0)2250
Cholesterol biosynthesis and metabolism CE(18:0)2250
Epoxysqualene Biosynthesis612
Farnesene Biosynthesis68
cis-Zeatin-O-Glucoside Biosynthesis313
cis-Zeatin-N-Glucoside Biosynthesis314
Metabolism of RNA63740
tRNA processing10729
tRNA modification in the nucleus and cytosol4325
tRNA modification in the mitochondrion95
Steroids metabolism ( Steroids metabolism )1627
Dimethylallyl diphosphate = Isopentenyl diphosphate ( Steroids metabolism )22
Cholesterol metabolism with Bloch and Kandutsch-Russell pathways039
Cholesterol Biosynthesis and Metabolism2248
Mevalonate Pathway1126
MEP/DOXP Pathway819
Cholesterol synthesis disorders015
Mevalonate pathway010
Ergosterol biosynthesis332
superpathway of sterol biosynthesis050
trans, trans-farnesyl diphosphate biosynthesis I05
Isoprenoid precursor biosynthesis in Pf apicoplasts012
GPP biosynthesis04
DXP pathway520
FPP biosynthesis05
Trans-zeatin biosynthesis022
GGPP biosynthesis II (plastidic)06
Kievitone biosynthesis16
Linear furanocoumarin biosynthesis015
MVA pathway116
Polyisoprenoid biosynthesis06
Wighteone and luteone biosynthesis19

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Butyrophilin subfamily 3 member A1Homo sapiens (human)IC50 (µMol)270.00004.56007.10009.6400AID1569596
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Undecaprenyl pyrophosphate synthetaseEscherichia coliKd520.0000520.0000520.0000520.0000AID977611
Butyrophilin subfamily 3 member A1Homo sapiens (human)EC50 (µMol)1.50000.00010.47193.0600AID1569591
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
positive regulation of cytokine productionButyrophilin subfamily 3 member A1Homo sapiens (human)
adaptive immune responseButyrophilin subfamily 3 member A1Homo sapiens (human)
positive regulation of type II interferon productionButyrophilin subfamily 3 member A1Homo sapiens (human)
activated T cell proliferationButyrophilin subfamily 3 member A1Homo sapiens (human)
T cell receptor signaling pathwayButyrophilin subfamily 3 member A1Homo sapiens (human)
regulation of cytokine productionButyrophilin subfamily 3 member A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
protein bindingButyrophilin subfamily 3 member A1Homo sapiens (human)
signaling receptor bindingButyrophilin subfamily 3 member A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneButyrophilin subfamily 3 member A1Homo sapiens (human)
external side of plasma membraneButyrophilin subfamily 3 member A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1576010Substrate activity at recombinant N-terminal His6-fusion tagged Aspergillus fumigatus FgaPT2 expressed in Escherichia coli BL21 (DE3) assessed as ratio of Kcat/Km in presence of L-tryptophan by Michaelis-Menten plot analysis2019MedChemComm, Aug-01, Volume: 10, Issue:8
FgaPT2, a biocatalytic tool for alkyl-diversification of indole natural products.
AID1569584Activation of BTN3A1 in human PBMC-derived Vgamma9/Vdelta2 T cells assessed as induction of IL2-stimulated cell proliferation by measuring increase in CD3+ cells preincubated for 3 days followed by 11 days incubation post compound washout and subsequent I2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1163703Inhibition of Populus trichocarpa DXS2014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.
AID221770Effective concentration to activate gammadelta T cells2002Journal of medicinal chemistry, Oct-24, Volume: 45, Issue:22
Quantitative structure--activity relations for gammadelta T cell activation by phosphoantigens.
AID1569591Activation of BTN3A1 in human PBMC-derived Vgamma9/Vdelta2 T cells assessed as induction of IL2-stimulated IFNgamma production measured after 48 hrs by ELISA2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1576008Substrate activity at recombinant N-terminal His6-fusion tagged Aspergillus fumigatus FgaPT2 expressed in Escherichia coli BL21 (DE3) assessed as Kcat in presence of L-tryptophan by Michaelis-Menten plot analysis2019MedChemComm, Aug-01, Volume: 10, Issue:8
FgaPT2, a biocatalytic tool for alkyl-diversification of indole natural products.
AID1576006Substrate activity at recombinant N-terminal His6-fusion tagged Aspergillus fumigatus FgaPT2 expressed in Escherichia coli BL21 (DE3) assessed as alkylation of L-tryptophan by measuring product formation at pH 7.5 in Tris buffer after 16 hrs by RP-HPLC an2019MedChemComm, Aug-01, Volume: 10, Issue:8
FgaPT2, a biocatalytic tool for alkyl-diversification of indole natural products.
AID1569594Displacement of GDP-BODIPY from C-terminal 6His-tagged BTN3A1 full interaction domain (unknown origin) expressed in Escherichia coli BL21 (DE) measured after 60 mins in presence of calcium by fluorescence polarization assay2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1569596Displacement of GDP-BODIPY from C-terminal 6His-tagged BTN3A1 B30.2 domain (unknown origin) expressed in Escherichia coli BL21 (DE) measured after 60 mins by fluorescence polarization assay2019Journal of medicinal chemistry, 07-25, Volume: 62, Issue:14
Probing the Ligand-Binding Pocket of BTN3A1.
AID1576009Substrate activity at recombinant N-terminal His6-fusion tagged Aspergillus fumigatus FgaPT2 expressed in Escherichia coli BL21 (DE3) assessed as Km in presence of L-tryptophan by Michaelis-Menten plot analysis2019MedChemComm, Aug-01, Volume: 10, Issue:8
FgaPT2, a biocatalytic tool for alkyl-diversification of indole natural products.
AID1811Experimentally measured binding affinity data derived from PDB2005The Journal of biological chemistry, May-27, Volume: 280, Issue:21
Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2005The Journal of biological chemistry, May-27, Volume: 280, Issue:21
Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (189)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (2.12)18.7374
1990's11 (5.82)18.2507
2000's58 (30.69)29.6817
2010's95 (50.26)24.3611
2020's21 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 15.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index15.21 (24.57)
Research Supply Index5.26 (2.92)
Research Growth Index5.29 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (15.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews18 (9.42%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other173 (90.58%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]